Joop J.
- Country
- Belgium
- Department
- Intensive Care
Research Overview
- An interventional efficacy and safety Phase 3 double-blind 2-arm study to investigate IV followed by oral fosmanogepix compared with IV caspofungin followed by oral fluconazole in adult participants with candidemia and/or invasive candidiasis.
- Phase 2 Evaluation of Inhaled Interferon Beta-1a (SNG001) in Mechanically Ventilated Patients with Lower Respiratory Tract Viral Infections
Data & Insights
Has run more than one trial at 6 of 63 partner sites.
Specializations
Critical Care Medicine
The investigator specializes in treating patients with post-cardiac conditions, focusing on cardiopulmonary resuscitation outcomes and cardiac arrest complications.
- Post-resuscitation care
- Neurological monitoring
- Emergency cardiac care
Key interest in managing comatose patients following cardiac events.
Neurology
Expertise in treating neurological complications, particularly status epilepticus in post-cardiac arrest scenarios, utilizing advanced EEG monitoring techniques.
- Electroencephalographic monitoring
- Seizure management
- Anti-seizure therapeutics
Special focus on neurological outcomes in critical care settings.
Infectious Diseases
The investigator concentrates on severe fungal infections, specifically candidemia and invasive candidiasis in adult patients.
- Antifungal therapy
- Systemic fungal infections
- Novel therapeutic approaches
Particular interest in innovative treatment strategies for invasive fungal infections.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.